Jmb Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 0.85 Cr
as on 16-11-2024
- Company Age 10 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.01 Cr
as on 16-11-2024
- Revenue 71.50%
(FY 2023)
- Profit 298.29%
(FY 2023)
- Ebitda -12.99%
(FY 2023)
- Net Worth 37.74%
(FY 2023)
- Total Assets -3.44%
(FY 2023)
About Jmb Pharmaceuticals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.85 Cr.
The company currently has active open charges totaling ₹4.01 Cr.
Benno Nangani and John Marina serve as directors at the Company.
- CIN/LLPIN
U32503MH2014PTC256657
- Company No.
256657
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Jmb Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Benno Nangani  | Director | 28-Jul-2014 | Current |
| John Marina | Director | 30-Nov-2021 | Current |
Financial Performance and Corporate Structure Insights of Jmb Pharmaceuticals.
Jmb Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 71.5% increase. The company also saw a substantial improvement in profitability, with a 298.29% increase in profit. The company's net worth Soared by an impressive increase of 37.74%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jmb Pharmaceuticals?
In 2022, Jmb Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 01 Jun 2020 | ₹2.00 M | Open |
Others Creation Date: 01 Jun 2020 | ₹2.10 M | Open |
Others Creation Date: 16 May 2016 | ₹1.00 M | Open |
How Many Employees Work at Jmb Pharmaceuticals?
Unlock and access historical data on people associated with Jmb Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jmb Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jmb Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
